State Street Corp Matinas Bio Pharma Holdings, Inc. Transaction History

State Street Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.15 - $0.37 $15,930 - $39,294	106,200 Added 16.09%	766,071 $122,000
Q1 2024 May 15, 2024	SELL	$0.19 - $0.3 $9,994 - $15,780	-52,600 Reduced 7.38%	659,871 $178,000
Q1 2022 May 16, 2022	BUY	$0.5 - $1.06 $26,448 - $56,070	52,897 Added 8.02%	712,471 $573,000
Q2 2021 Aug 16, 2021	BUY	$0.75 - $1.1 $393,430 - $577,031	524,574 Added 388.57%	659,574 $511,000
Q1 2021 May 17, 2021	BUY	$0.96 - $1.74 $7,968 - $14,442	8,300 Added 6.55%	135,000 $142,000
Q1 2020 May 11, 2020	BUY	$0.6 - $2.31 $76,020 - $292,677	126,700 New	126,700 $76,000

3.52M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $130M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.